Хайлтын үр дүнгүүд - Dimitri Breems

  • 13-н 1 - 13 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    Stroma-Contact Prevents Loss of Hematopoietic Stem Cell Quality During Ex Vivo Expansion of CD34+ Mobilized Peripheral Blood Stem Cells

    Stroma-Contact Prevents Loss of Hematopoietic Stem Cell Quality During Ex Vivo Expansion of CD34+ Mobilized Peripheral Blood Stem Cells -н Dimitri Breems, Ellen A.W. Blokland, Karen E. Siebel, Angelique E. M. Mayen, Lilian J.A. Engels, Rob E. Ploemacher

    Хэвлэсэн 1998
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

    Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype -н Dimitri Breems, Wim L.J. van Putten, Georgine E. de Greef, Shama L. van Zelderen‐Bhola, Klasien B.J. Gerssen‐Schoorl, Clemens Mellink, Aggie Nieuwint, Martine Jotterand, Anne Hagemeijer, H. Berna Beverloo, Bob Löwenberg

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories

    Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories -н Jan J. Cornelissen, Dimitri Breems, Wim L.J. van Putten, Aloïs Gratwohl, Jakob Passweg, Thomas Pabst, Johan Maertens, H. Berna Beverloo, Marinus van Marwijk Kooy, Pierre W. Wijermans, Bart J. Biemond, Edo Vellenga, Leo F. Verdonck, Gert J. Ossenkoppele, Bob Löwenberg

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival

    Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively aff... -н Jesse M. Tettero, Lok Lam Ngai, Costa Bachas, Dimitri Breems, Thomas Fischer, Bjørn Tore Gjertsen, Patrycja Gradowska, Laimonas Griškevičius, Jeroen J.W.M. Janssen, Gunnar Juliusson, Johan Maertens, Markus G. Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter J.M. Valk, Bob Löwenberg, Gert J. Ossenkoppele, Jacqueline Cloos

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Carta
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study

    Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study -н Bob Löwenberg, Joachim Beck, Carlos Graux, Wim van Putten, Harry C. Schouten, Leo F. Verdonck, Augustin Ferrant, Pieter Sonneveld, Mojca Jongen‐Lavrencic, Marie von Lilienfeld‐Toal, Bart J. Biemond, Edo Vellenga, Dimitri Breems, Hilde de Muijnck, Ron Schaafsma, Gregor Verhoef, Hartmut Döhner, Aloïs Gratwohl, Thomas Pabst, Gert J. Ossenkoppele, Johan Maertens

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients

    Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients -н Gerwin Huls, Dana Chiţu, Violaine Havelange, Mojca Jongen‐Lavrencic, Arjan A. van de Loosdrecht, Bart J. Biemond, Harm Sinnige, Beata Hodossy, Carlos Graux, Rien van Marwijk Kooy, Okke de Weerdt, Dimitri Breems, Saskia K. Klein, Jürgen Kuball, Dries Deeren, Wim Terpstra, Marie‐Christiane Vekemans, Gert J. Ossenkoppele, Edo Vellenga, Bob Löwenberg

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Molecular characterization of mutant <i>TP53</i> acute myeloid leukemia and high-risk myelodysplastic syndrome

    Molecular characterization of mutant <i>TP53</i> acute myeloid leukemia and high-risk myelodysplastic syndrome -н Tim Grob, Adil S. A. Al Hinai, Mathijs A. Sanders, François G. Kavelaars, Melissa Rijken, Patrycja Gradowska, Bart J. Biemond, Dimitri Breems, Johan Maertens, Marinus van Marwijk Kooy, Thomas Pabst, Okke de Weerdt, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Gerwin Huls, Jan J. Cornelissen, H. Berna Beverloo, Bob Löwenberg, Mojca Jongen‐Lavrencic, Peter J.M. Valk

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents

    CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents -н Tom Reuvekamp, Lok Lam Ngai, Daphne den Hartog, Jannemieke Carbaat‐Ham, Mona M.H.E Fayed, Willemijn J. Scholten, Tim R. Mocking, Dana Chiţu, Thomas Pabst, Saskia K. Klein, Georg Stüssi, Laimonas Griškevičius, Dimitri Breems, Daniëlle van Lammeren‐Venema, Rinske Boersma, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Costa Bachas, Gerwin Huls, David C. de Leeuw, Jacqueline Cloos

    Хэвлэсэн 2025
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)

    Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON)... -н Gert J. Ossenkoppele, Georg Stüssi, Johan Maertens, Kees van Montfort, Bart J. Biemond, Dimitri Breems, A. Ferrant, Carlos Graux, Georgine E. de Greef, Constantijn J.M. Halkes, Mels Hoogendoorn, Rene Hollestein, Mojca Jongen‐Lavrencic, Mark Levin, Arjan A. van de Loosdrecht, Marinus van Marwijk Kooij, Yvette van Norden, Thomas Pabst, Harry C. Schouten, Edo Vellenga, Gregor Verhoef, Okke de Weerdt, P. Wijermans, Jakob Passweg, Bob Löwenberg

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years

    Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years -н Jan J. Cornelissen, Jurjen Versluis, Jakob Passweg, Wim L.J. van Putten, Markus G. Manz, Johan Maertens, H. Berna Beverloo, Peter J.M. Valk, Marinus van Marwijk Kooy, P. Wijermans, Martyn Ronald Schaafsma, Bart J. Biemond, MC Vekemans, Dimitri Breems, Leo F. Verdonck, Martin F. Fey, Mojca Jongen‐Lavrencic, Jeroen J.W.M. Janssen, Gerwin Huls, Jürgen Kuball, Thomas Pabst, Carlos Graux, Harry C. Schouten, Aloïs Gratwohl, Edo Vellenga, G.J. Ossenkoppele, Bob Löwenberg

    Хэвлэсэн 2014
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

    Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML -н Bob Löwenberg, Thomas Pabst, Johan Maertens, Yvette van Norden, Bart J. Biemond, Harry C. Schouten, Olivier Spertini, Edo Vellenga, Carlos Graux, Violaine Havelange, Georgine E. de Greef, Okke de Weerdt, Marie-Cecile J. C. Legdeur, Juergen Kuball, Marinus van Marwijk Kooy, Bjørn Tore Gjertsen, Mojca Jongen‐Lavrencic, Arjan A. van de Loosdrecht, Daniëlle van Lammeren‐Venema, Beata Hodossy, Dimitri Breems, Yves Chalandon, Jakob Passweg, Peter J.M. Valk, Markus G. Manz, Gert J. Ossenkoppele

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

    Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia -н Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Lionel Karlin, Tadeusz Robak, Douglas E. Gladstone, Philipp le Coutre, Sascha Dietrich, Mirjana Gotić, Loree Larratt, Fritz Offner, Gary J. Schiller, Ronan Swords, Larry Bacon, Monica Bocchia, Krimo Bouabdallah, Dimitri Breems, Agostino Cortelezzi, Shira Dinner, Michael Doubek, Bjørn Tore Gjertsen, Marco Gobbi, Andrzej Hellmann, Stéphane Leprêtre, Frédéric Maloisel, Farhad Ravandi, Philippe Rousselot, Mathias Rummel, Tanya Siddiqi, Tamar Tadmor, Xavier Troussard, Cecilia Arana Yi, Giuseppe Saglio, Gail J. Roboz, Kemal Balic, Nathan Standifer, Peng He, Shannon Marshall, Wyndham H. Wilson, Ira Pastan, Nai-Shun Yao, Francis J. Giles

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

    Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial -н Bob Löwenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griškevičius, Lidwine W. Tick, Mojca Jongen‐Lavrencic, Marinus van Marwijk Kooy, Marie-Christiane Vekemans, Walter J. F. M. van der Velden, Berna Beverloo, Lucienne Michaux, Carlos Graux, Dries Deeren, Okke de Weerdt, Joost W. J. van Esser, Mario Bargetzi, Saskia K. Klein, Alain Gadisseur, Peter E. Westerweel, Hendrik Veelken, Michael Gregor, Tobias Silzle, Daniëlle van Lammeren-Venema, Ine Moors, Dimitri Breems, Mels Hoogendoorn, Marie-Cecile J. C. Legdeur, Thomas Fischer, Juergen Kuball, Jan J. Cornelissen, Kimmo Porkka, Gunnar Juliusson, Peter Meyer, Martin Höglund, Bjørn Tore Gjertsen, Jeroen J.W.M. Janssen, Gerwin Huls, Jakob Passweg, Jacqueline Cloos, Peter J.M. Valk, Catharina H. M. J. Van Elssen, Markus G. Manz, Yngvar Fløisand, Gert J. Ossenkoppele

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: